Introduction {#s1}
============

Stress, defined as the physiological response of the body to any demand ([@B1]), serves the principal goal to mobilize energy for appropriate, fight or flight\' response. The primary response includes the activation of the sympathetic nervous system and the hypothalamus-pituitary-adrenal axis, resulting in the secretion of catecholamines and glucocorticoids from the adrenal gland. Albeit this adaptation promotes survival of physical threats to homeostasis, chronic psychosocial threats are well-known to adversely affect human health ([@B2]--[@B4]).

Chronic psychosocial stress, particularly in conjunction with viral hepatitis, cirrhosis, and hepatocellular carcinoma is thought to contribute to the development and progression of liver disease ([@B5]). For instance, a comparison of the mortality in the general population between periods of economic crisis and periods prior or after the crisis revealed an increased all-cause mortality, due among others to an increased incidence of chronic liver disease ([@B3]). Moreover, chronic stress is a well-known risk factor for the development of obesity and metabolic syndrome ([@B6], [@B7]). Animal studies further support the hypothesis that chronic stress induces ([@B8]) and aggravates ([@B9], [@B10]) liver injury, causes hepatic oxidative stress ([@B11], [@B12]) and insulin resistance ([@B13]), alters hepatic metabolism and gene transcription ([@B14]), and disrupts the regulation of lipid synthesis ([@B15]).

Sphingolipids (SL) comprise a class of lipids with important structural functions and relevance in cell signaling ([@B16]). Bioactive SL play a role in the regulation of cell growth, death, senescence, adhesion, migration, inflammation, angiogenesis, and intracellular trafficking ([@B17]). Ceramides (Cer) constitute a family of lipid species ([@B18]) that are central to SL metabolism as they serve as precursors for the biosynthesis of plasma membrane SL such as glycosphingolipids (GSL) or sphingomyelins (SM), and, alternatively, can be metabolized into other bioactive SL such as ceramide-1-phoshate, sphingosine, and sphingosine-1-phosphate. Additionally, Cer modulate a number of biochemical and cellular processes induced by stressor exposure, including apoptosis, cell-cycle arrest and cell senescence. Moreover, several extracellular challenges, such as tumor necrosis factor (TNF)-α, chemotherapeutic agents and heat, cause Cer accumulation ([@B19]). Increased Cer levels, in turn, are supposed to contribute to the development of several human diseases, including liver diseases ([@B20]). Cer can be synthesized *de novo* from serine and palmitoyl-CoA or by re-acylation of sphingosine in a salvage pathway. Cer can be also generated by the breakdown of SL from biological membranes. Acid sphingomyelinase (here referred to as ASM for human protein and Asm for mouse protein) is one of several mammalian sphingomyelinases that catalyzes the breakdown of SM to Cer and phosphorylcholine ([@B21]). Activity of ASM is sensitive to cellular stress and is activated, among others, by TNF-α ([@B22]), oxidative stress ([@B23]), and ionizing radiation ([@B24]). In line with these findings, recent studies provided evidence that both stress-associated disorders, as for instance major depression ([@B25]), chronic heart failure ([@B26]), acute and chronic alcohol consumption ([@B27], [@B28]), and chronic hepatitis C infection ([@B29]), as well as various chronic unpredictable stressors ([@B25], [@B30]), have been associated with increased ASM activity and Cer levels, respectively.

However, it is unknown to date whether this holds true for chronic stressors which are psychosocial in nature. We therefore analyzed mice subjected to the chronic subordinate colony housing (CSC) paradigm, a pre-clinically validated mouse model for chronic psychosocial stress ([@B31]). Importantly, besides typical stress symptoms such as adrenal hypertrophy, thymus atrophy, and increased plasma nor-epinephrine levels, CSC exposure reliably causes anxiety and spontaneous colitis, increases the risk for colon cancer ([@B32]), and induces hepatic inflammation and oxidative stress ([@B11]). Our analysis of serum samples and liver specimen revealed that chronic psychosocial stress is associated with increased Asm activity, increased levels of C16:0-Cer, a decline in C24:0-Cer, and increased expression levels of *Cers5, Cers6, Gba, Gba2, Ormdl2*, and *Smpdl3b* mRNA. Thus, a shift in the SL composition toward an accumulation of C16:0-Cer might be the origin of the adverse health effects associated with chronic psychosocial stress.

Methods {#s2}
=======

Animal specimens
----------------

Liver and serum specimens of male C57BL/6 mice (Charles River, Sulzfeld, Germany) that were either exposed to CSC (*n* = 8) for 19 days or kept as SHC (*n* = 8) were analyzed. Animals and procedures are described in detail in Czech et al. ([@B11]). Briefly, four CSC mice were housed together with a larger dominant male in a polycarbonate observation cage (38 × 22 × 35 cm) for 19 d consecutively. Prior to CSC exposure, all potential male dominant mice were tested for their aggressive behavior. Males that started to injure their opponents by harmful bites were not used for the CSC procedure. To avoid habituation, each dominant male was replaced by a novel dominant male on days 8 and 15. Serum of independent CSC and SHC groups (each *n* = 8) was used to confirm results. All experimental protocols were approved by the Committee on Animal Health and Care of the Government of Oberpfalz (Permit Number: 54-2531.2-16/08) and conform to international guidelines on the ethical use of animals.

Preparation of tissue lysates and determination of Asm activity
---------------------------------------------------------------

Asm activity was determined from liver homogenates and from serum. Tissue, homogenates and serum were stored at −80°C prior to the analysis. For the preparation of liver homogenates, pieces of 10--20 mg tissue were homogenized in 0.5 ml sucrose lysis buffer (250 mM sucrose, 1 mM EDTA, 0.2% Triton X-100) using a TissueLyser LT bead mill (Qiagen). Raw lysates were centrifugated with ≥10,000 g at 4 °C for 10 min, and supernatants were transferred to new tubes. The protein concentrations were determined using bicinchoninic acid kit (Sigma). For the determination of Asm activity from liver homogenates, 1 μg of protein were incubated with 0.58 μM *N*-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-dodecanoyl)-sphingosylphosphocholine (BODIPY® FL C~12~-sphingomyelin; D-7711; Life Technologies, Darmstadt, Germany) in 50 μl reaction buffer (50 mM sodium acetate pH 5.0, 0.3 M NaCl, 0.2% NP-40) for 2 h at 37°C; after incubation, 3 μl of the reaction volume was spotted on a silica gel 60 plate (Macherey-Nagel; Düren, Germany), and Cer and SM were separated by thin layer chromatography using 99% ethyl acetate/1% acetic acid (v/v) as a solvent ([@B33]). Intensity of BODIPY-conjugated Cer and SM fractions were determined using a Typhoon Trio scanner (GE Healthcare, München, Germany) and quantified with QuantityOne software (Biorad, München, Germany). For each liver specimen, Asm activity was determined twice from two independent pieces of tissue with similar results. Activity of secretory (S-) Asm was measured with the same protocol using 2 μl of serum and with additional 500 μM ZnCl~2~ in the reaction buffer.

Quantification of ceramide and sphingomyelin species by mass spectrometry
-------------------------------------------------------------------------

Cer and SM were extracted and quantified as described previously ([@B25]). Briefly, lipid extraction was performed from 100 μl liver homogenates containing 50 μg total protein using C17:0-Cer and deuterated C16-d31 SM (N-palmitoyl-d31-D-*erythro*-sphingomyelin; Avanti Polar Lipids) as internal standards. Sample analysis was carried out by rapid-resolution liquid chromatography-MS/MS using a Q-TOF 6,530 mass spectrometer (Agilent Technologies, Waldbronn, Germany) operating in the positive ESI mode. The precursor ions of Cer species \[C16:0-Cer (m/z 520.508), C17:0-Cer (m/z 534.524), C18:0-Cer (m/z 548.540), C20:0-Cer (m/z 576.571), C22:0-Cer (m/z 604.602), C24:0-Cer (m/z 632.634), C24:1-Cer (m/z 630.618)\] were cleaved into the fragment ion m/z 264.270. The precursor ions of SM species \[C16:0-SM (m/z 703.575), C16-d31 SM (m/z 734.762), C18:0-SM (m/z 731.606), C20:0-SM (m/z 759.638), C22:0-SM (m/z 787.669), C24:0-SM (m/z 815.700), C24:1-SM (m/z 813.684)\] were cleaved into the fragment ion m/z 184.074. Quantification was performed with Mass Hunter Software (Agilent Technologies).

Extraction of RNA and synthesis of cDNA
---------------------------------------

Total RNA was isolated from pieces of liver tissues (\<30 mg) using a TissueLyser LT bead mill (Qiagen) and peqGOLD Trifast reagent (Peqlab, Erlangen, Germany) according to manufacturers\' instructions. RNA qualities and concentrations were assessed using a Nanodrop ND-1000 UV-Vis spectrophotometer. SuperScript VILO cDNA synthesis kit (Invitrogen) was used to reverse transcribe 1 μg RNA into cDNA using 2 μl 5x VILO reaction mix and 1 μl 10x SuperScript enzyme mix in a final volume of 10 μl. After completion and termination of the RT reaction, cDNA was diluted with 190 μl LowTE and stored at −20°C.

Quantitative PCR analysis
-------------------------

Quantitative real-time PCR was performed using a LightCycler 480 real-time PCR system (Roche, Germany) and SYBR-green chemistry. In detail, qPCR reactions contained 5 μl FastStart Essential DNA Green Master, 1 μM of each primer and 2.5 μl diluted cDNA (corresponding to 12.5 ng RNA) in a total volume of 10 μl. Temperature profile used was: 95°C for 5 min followed by 45 cycles of amplification (95°C for 10 s, 60°C for 20 s, 72°C for 30 s) and by melting curve analysis. After run, PCR product specificity was assessed by the inspection of single peak melting curves, and threshold cycles (Ct) were determined with the second derivative maximum method using the LightCycler 480 software (release 1.5.0). Gene-specific primers were either selected from the literature or from PrimerBank (<https://pga.mgh.harvard.edu/primerbank/>) or designed via the Universal Probe Library Assay Design Center (<http://qpcr.probefinder.com/organism.jsp>). Reference genes were tested and selected according to their gene expression stability ([@B34]), and a normalization factor was calculated based on the geometric mean of the reference genes *Rpl32, Rpl38, Hprt*, and *Gusb* ([@B34]) using the SLqPCR package in R version 3.2.2. Relative mRNA expression levels were calculated in Microsoft Excel using the 2^−ΔΔCt^ method ([@B35]). The sequence of primers is given in Table [1](#T1){ref-type="table"}.

###### 

Sequence of primers used in this study.

  **No**.   **MGI Symbol**   **Gene name**                                            **RefSeq**                     **Fwd primer**                   **Rev primer**
  --------- ---------------- -------------------------------------------------------- ------------------------------ -------------------------------- -------------------------------
  1         Asah1            N-acylsphingosine amidohydrolase 1                       [NM_019734](NM_019734)         5′-TGAAGATGGTGGATCAAAAGC-3′      5′-ACATCTGCAATTCCCCTCA-3′
  2         Asah2            N-acylsphingosine amidohydrolase 2                       [NM_018830](NM_018830)         5′-TTCTCACCCTCTTGTTTGTTACC-3′    5′-AGGGAAGTTTGGAGTCTGTGT-3′
  3         Cerk             Ceramide kinase                                          [NM_145475](NM_145475)         5′-TCCGTGCTGTGGGTGAAAC-3′        5′-CGCAGTCGTCTTTTTCCTCAA-3′
  4         Cers1            Ceramide synthase 1                                      [NM_138647](NM_138647)         5′-CCACCACACACATCTTTCGG-3′       5′-GGAGCAGGTAAGCGCAGTAG-3′
  5         Cers2            Ceramide synthase 2                                      [NM_029789](NM_029789)         5′-AGAGTGGGCTCTCTGGACG-3′        5′-CCAGGGTTTATCCACAGTGAC-3′
  6         Cers3            ceramide synthase 3                                      [NM_001164201](NM_001164201)   5′-CCTGGCTGCTATTAGTCTGATG-3′     5′-CTGCTTCCATCCAGCATAGG-3′
  7         Cers4            Ceramide synthase 4                                      [NM_026058](NM_026058)         5′-CTGTGGTACTGTTGTTGCATGAC-3′    5′-GCGCGTGTAGAAGAAGACTAAG-3′
  8         Cers5            Ceramide synthase 5                                      [NM_028015](NM_028015)         5′-GACTGCTTCCAAAGCCTTGAG-3′      5′-GCAGTTGGCACCATTGCTAG-3′
  9         Cers6            Ceramide synthase 6                                      [NM_172856](NM_172856)         5′-GGAGCTGTCATTTTATTGGTCTTT-3′   5′-GGAACATAATGCCGAAGTCC-3′
  10        Galc             Galactosylceramidase                                     [NM_008079](NM_008079)         5′-CGCCTACGTGCTAGACGAC-3′        5′-ACGATAGGGCTCTGGGTAATTT-3′
  11        Gba              Glucosidase, beta, acid                                  [NM_008094](NM_008094)         5′-TTTGGTAAAGCACCTCGGTATG-3′     5′-GCATGTCGATGAAAGGGGTCT-3′
  12        Gba2             Glucosidase beta 2                                       [NM_172692](NM_172692)         5′-TTTGGTAAAGCACCTCGGTATG-3′     5′-GCATGTCGATGAAAGGGGTCT-3′
  13        Ormdl1           ORM1-like 1                                              [NM_145517](NM_145517)         5′-ACAGTGAGGTAAACCCCAATACT-3′    5′-GCAAAAACACATACATCCCCAGA-3′
  14        Ormdl2           ORM1-like 2                                              [NM_024180](NM_024180)         5′-CCTGGAGACCACAGGTGTAAG-3′      5′-AGCCCTGATTGAGCTTGTTC-3′
  15        Ormdl3           ORM1-like 3                                              [NM_025661](NM_025661)         5′-ACCCTCACCAACCTTATCCA-3′       5′-GTCAGCAACCTTGCTTTGC-3′
  16        Sgms1            Sphingomyelin synthase 1                                 [NM_001168525](NM_001168525)   5′-GAGCTGTGACCTTTTGAGCA-3′       5′-TTATATCCAGTTGCCCCTGTG-3′
  17        Sgms2            Sphingomyelin synthase 2                                 [NM_028943](NM_028943)         5′-TTACCTGTGCCCGGAATG-3′         5′-TTTGCCTGAGAGTCTCCATTG-3′
  18        Sgpl1            Sphingosine phosphate lyase 1                            [NM_009163](NM_009163)         5′-CTGAAGGACTTCGAGCCTTATTT-3′    5′-ACTCCACGCAATGAGCTGC-3′
  19        Sgpp1            Sphingosine-1-phosphate phosphatase 1                    [NM_030750](NM_030750)         5′-TACGGGCTGATTCTCATTCCC-3′      5′-GGTCCACCAATGGGTAGAAGA-3′
  20        Sgpp2            Sphingosine-1-phosphate phosphotase 2                    [NM_001004173](NM_001004173)   5′-TCTACCATGGACCGGTATCAG-3′      5′-GAGACACACCAGCGTAGAGAAC-3′
  21        Smpd1            Sphingomyelin phosphodiesterase 1, acid lysosomal        [NM_011421.](NM_011421.)       5′-TGCTGAGAATCGAGGAGACA-3′       5′-GACCGGCCAGAGTGTTTTC-3′
  22        Smpd3            Sphingomyelin phosphodiesterase 3                        [NM_021491](NM_021491)         5′-TCTACCTCCTCGACCAGCAC-3′       5′-TGCTGCTCCAGTTTGTCATC-3′
  23        Smpdl3a          Sphingomyelin phosphodiesterase, acid-like               [NM_020561](NM_020561)         5′-TCCTTTGCTGCCTACTGGTT-3′       5′-TCAGTCACGTGCCAAAACTG-3′
  24        Smpdl3b          Sphingomyelin phosphodiesterase, acid-like 3B            [NM_133888](NM_133888)         5′-TTGTGGAACGCTTGACCAAC-3′       5′-GAACTGGTTCTTAGGGTGGAAG-3′
  25        Sphk1            Sphingosine kinase 1                                     [NM_011451](NM_011451)         5′-GGTGAATGGGCTAATGGAACG-3′      5′-CTGCTCGTACCCAGCATAGTG-3′
  26        Sphk2            Sphingosine kinase 2                                     [NM_203280](NM_203280)         5′-TCTGGAGACGGGCTGCTTTA-3′       5′-TCAAACCCGCCATGATGGTTC-3′
  27        Sptlc1           Serine palmitoyltransferase, long chain base subunit 1   [NM_009269](NM_009269)         5′-ACGAGGCTCCAGCATACCAT-3′       5′-TCAGAACGCTCCTGCAACTTG-3′
  28        Sptlc2           Serine palmitoyltransferase, long chain base subunit 2   [NM_011479](NM_011479)         5′-AACGGGGAAGTGAGGAACG-3′        5′-CAGCATGGGTGTTTCTTCAAAAG-3′
  29        Sptlc3           Serine palmitoyltransferase, long chain base subunit 3   [NM_175467](NM_175467)         5′-TCTGAACGACAGTGCTGTTAC-3′      5′-ATGCCTTCCTATTTTGCTGGG-3′
  30        Ugcg             UDP-glucose ceramide glucosyltransferase                 [NM_011673](NM_011673)         5′-GGAATGGCCTTGTTCGGCT-3′        5′-CGGCTGTTTGTCTGTTGCC-3′
  31        Ugt8a            UDP galactosyltransferase 8A                             [NM_011674](NM_011674)         5′-TCAGAAGACATTGCCAACAAA-3′      5′-GGTTCTTTGGTTTGGTTCCAG-3′
  33        Tnf              Tumor necrosis factor                                    [NM_013693](NM_013693)         5′-CTGTAGCCCACGTCGTAGC-3′        5′-TTGAGATCCATGCCGTTG-3′
  34        Hmox1            Heme oxygenase 1                                         [NM_010442](NM_010442)         5′-AGGCTAAGACCGCCTTCCT-3′        5′-TGTGTTCCTCTGTCAGCATCA-3′
  35        Bmp4             Bone morphogenetic protein 4                             [NM_007554](NM_007554)         5′-GAGGAGTTTCCATCACGAAGA-3′      5′-GCTCTGCCGAGGAGATCA-3′
  37        Gusb             Glucuronidase, beta                                      [NM_010368](NM_010368)         5′-GATGTGGTCTGTGGCCAAT-3′        5′-TGTGGGTGATCAGCGTCTT-3′
  38        Gapdh            Glyceraldehyde-3-phosphate dehydrogenase                 [NM_008084](NM_008084)         5′-AGGTCGGTGTGAACGGATTTG-3′      5′-TGTAGACCATGTAGTTGAGGTCA-3′
  39        Hprt             Hypoxanthine guanine phosphoribosyl transferase          [NM_013556.](NM_013556.)       5′-CCTCCTCAGACCGCTTTTT-3′        5′-AACCTGGTTCATCATCGCTAA-3′
  40        Rpl32            Ribosomal protein L32                                    [NM_172086](NM_172086)         5′-TTAAGCGAAACTGGCGGAAAC-3′      5′-TTGTTGCTCCCATAACCGATG-3′
  41        Pmm1             Phosphomannomutase 1                                     [NM_013872](NM_013872)         5′-GTCCTGGCGGGAATGACTTT-3′       5′-TGGGCTGTCTCTGGGAAGAA-3′
  42        Rpl38            Ribosomal protein L38                                    [NM_001048057](NM_001048057)   5′-AGGATGCCAAGTCTGTCAAGA-3′      5′-TCCTTGTCTGTGATAACCAGGG-3′

Statistical analyses
--------------------

Statistical analyses were performed using the IBM SPSS Statistics version 21. Continuous variables were tested for deviation from normal distributions using the Kolmogorov--Smirnov test. Statistical significance of measurements between SHC and CSC mice was determined using ANOVA. A two-sided *P* \< 0.05 was considered to indicate statistical significance. All results are presented as mean value ± standard deviation (SD). Graphs were created with GraphPad Prism for Windows, Version 4.01 (Graphpad Software, LaJolla, CA) or with MS Excel 2010.

Results {#s3}
=======

Asm activities are elevated in stressed mice
--------------------------------------------

Hepatic Asm activity in CSC mice was increased by 28% in comparison to SHC mice (Figure [1A](#F1){ref-type="fig"}; relative Asm activity in SHC: 1.00 ± 0.18, *n* = 8; CSC: 1.28 ± 0.17, *n* = 8; *P* = 0.006). We also determined activity of S-Asm in serum. S-Asm activity of CSC mice was increased by 57% (Figure [1B](#F1){ref-type="fig"}; relative S-Asm activity in SHC: 1.00 ± 0.34, *n* = 16; CSC: 1.57 ± 0.37, *n* = 14; *P* = 0.0001).

![Chronic psychosocial stress is associated with increased Asm activity in liver and serum. Asm activity in liver **(A)** and serum **(B)** of SHC and CSC mice (each *n* = 8 for liver and *n* = 16 for serum). For ease of comparison, activities of SHC mice was set to 1. Data are presented as mean values ± SD. Asterisks indicate statistical significance CSC vs. SHC (\*\**p* \< 0.01, \*\*\**p* \< 0.0001). CSC, chronic subordinate colony housing; SHC, single housed controls.](fpsyt-09-00496-g0001){#F1}

Stressed mice display higher percentage of C16:0-ceramide
---------------------------------------------------------

Hepatic tissue was subjected to lipidomic analyses to determine Cer and SM content. Total Cer (SHC: 643 ± 63.4 pmol/mg protein, *n* = 8; CSC: 640 ± 68.9 pmol/mg protein, *n* = 8; *P* = 0.927) and SM levels (SHC: 2,320 ± 239 pmol/mg protein, *n* = 8; CSC: 2.677 ± 440 pmol/mg protein, *n* = 8; *P* = 0.064) were not increased in CSC mice. To assess the relative composition of the hepatic Cer pool, we calculated the relative percentage for every single species. The composition of the Cer pool was changed significantly in response to stress toward a higher percentage of long chain C16:0-Cer (from 13.5 to 18.8%, *P* = 0.017) and a lower percentage of Cer species with very-long saturated acyl chains (C22:0-Cer: 29.2 to 26.2%, *P* = 0.127; C24:0-Cer: 27.8 to 25.1%, *P* = 0.033) (Figure [2](#F2){ref-type="fig"}).

![Chronic psychosocial stress is associated with increased C16:0-Cer and decreased C24:0-Cer content in the liver. Given is the percentage of each Cer species with respect to total Cer quantity. Data are presented as mean values ± SD (*n* = 8 per group). Asterisks indicate statistical significance CSC vs. SHC (\**p* \< 0.05). Cer, ceramides; CSC, chronic subordinate colony housing; SM, sphingomyelines; SHC, single housed controls.](fpsyt-09-00496-g0002){#F2}

TNF-α mRNA expression is upregulated in CSC mice
------------------------------------------------

We further analyzed TNF-α mRNA expression levels in liver tissue. In agreement with a previous report ([@B11]), TNF-α mRNA was significantly increased in CSC compared to controls (SHC: 1.00 ± 0.42, *n* = 8; CSC: 2.43 ± 1.15, *n* = 8; *P* = 0.009).

RNA expression of SL metabolizing enzymes is upregulated in CSC mice
--------------------------------------------------------------------

To check if other pathways in addition to the SM hydrolyzing pathway via Asm were involved in the change of C16:0-Cer levels upon chronic psychosocial stress, we conducted a gene expression analysis of 31 genes involved in the metabolism of Cer in liver tissue (Table [1](#T1){ref-type="table"}). Three genes, ceramide synthase 1 (*Cers1*), ceramide synthase 3 (*Cers3*), and serine palmitoyltransferase, long chain base subunit 3 (*Sptlc3*) were not expressed in hepatic tissue (*data not shown*). A comparison of the normalized mRNA expression levels of the other 28 genes revealed that the majority was higher expressed in CSC compared to SHC mice (Table [2](#T2){ref-type="table"}). *Cers5, Cers6, Gba, Gba2, Ormdl2*, and *Smpdl3b* mRNA were significantly higher expressed in CSC mice compared to control mice (Figure [3](#F3){ref-type="fig"}).

###### 

Gene expression analysis of genes involved in SL metabolism.

  **MGI symbol**   **Change (%)**   ***P*-value**
  ---------------- ---------------- ---------------
  Asah1            3.88             0.719
  Asah2            −11.2            0.423
  Cerk             16.1             0.297
  Cers2            −25.2            0.162
  Cers4            −11.6            0.554
  **Cers5**        **35.9**         **0.028**
  **Cers6**        **66.9**         **0.045**
  Galc             16.9             0.162
  **Gba**          **28.9**         **0.049**
  **Gba2**         **39.7**         **0.030**
  Sgms1            20.7             0.198
  Sgms2            −4.79            0.756
  Sgpl1            −0.85            0.965
  Sgpp1            −1.88            0.911
  Sgpp2            11.7             0.656
  Smpd1            32.8             0.075
  Smpd3            90.5             0.130
  Sphk1            24.5             0.385
  Sphk2            −11.4            0.315
  Sptlc1           24.0             0.086
  Sptlc2           49.7             0.052
  Ugcg             18.3             0.220
  Ugt8a            −2.95            0.879
  Ormdl1           0.95             0.954
  **Ormdl2**       **39.9**         **0.034**
  Ormdl3           −0.32            0.984
  Smpdl3a          22.9             0.344
  **Smpdl3b**      **50.7**         **0.013**

*Significance of differentially expressed genes under chronic psychosocial stress was estimated using t-test. Genes with P \< 0.05 are given in bold*.

![Chronic psychosocial stress is associated with altered gene expression in the liver of enzymes regulating ceramide production. Relative mRNA expression of genes involved in sphingolipid metabolism. Vertical scatter plot of genes differentially expressed in CSC vs. SHC (*t-*tests, *P* \< 0.05). Selection of reference genes and calculation of the normalization factor was conducted according to Vandesompele et al. ([@B34]). For ease of comparison, transcript level in SHC mice was set to 1. Asterisks indicate statistical significance CSC vs. SHC (\**p* \< 0.05). CSC, chronic subordinate colony housing; SHC, single housed controls.](fpsyt-09-00496-g0003){#F3}

Discussion {#s4}
==========

In this study, we showed for the first time that chronic psychosocial stress in mice leads to the activation of Asm and, consequently, increased Cer levels, both assessed in hepatic tissue. In detail, increased Asm activity in mice exposed to chronic psychosocial stress was associated with increased concentration of C16:0-Cer and a decline of C24:0-Cer. Increased C16:0-Cer concentrations and especially a shift from very-long-chain C24:0-Cer to long chain C16:0-Cer in the SL composition is frequently observed ([@B36]) and confers susceptibility to cellular apoptosis ([@B37]) and steatohepatitis and insulin resistance ([@B38]). Thus, activation of Asm seems likely to constitute an important link between chronic psychosocial stress and its adverse health effects in the liver, but also in other organs.

Our analysis further revealed that chronic psychosocial stress affects other key aspects of sphingolipid regulation besides activation of ASM. By means of gene expression analysis we found that several enzymes involved in SL metabolism---*Cers5* and *Cers6, Gba, Gba2, Ormdl2*, and *Smpdl3b---*were upregulated under conditions of chronic psychosocial stress. Ceramide synthase (CerS) 5 and 6 (MGI symbol *Cers5* and *Cers6*) belong to a group of enzymes that catalyze the formation of ceramides by *N*-acylation of sphingoid bases. Each CerS has a high specificity toward the acyl chain length and, thus, the active CerS isozymes determine the fatty acid composition of Cer and the derived SL ([@B39]). Of the six mammalian CerSs we found four---*CerS2, CerS4, CerS5*, and *CerS6---*to be expressed in hepatic mouse tissue, while we could not detect transcripts of *CerS1* or *CerS3*. These results are in line with a previous report ([@B40]). Increased *CerS5* or *CerS6* activity can mediate the accumulation of C16:0-Cer ([@B41], [@B42]). Of note, several reports indicate that *CerS6* activity is controlled via transcriptional regulation ([@B42], [@B43]). Thus, increased expression of *CerS5* and *CerS6* following chronic psychosocial stress might be responsible for the shift in the cellular SL composition from very-long-chain Cer to long-chain C16-Cer and, thus, contribute to the adverse health effect of stress. However, since CerS are also regulated by post-translational mechanisms ([@B44], [@B45]), enzymatic activities of *CerS5* and *CerS6* under conditions of chronic psychosocial stress should to be determined before claiming a role in stress-induced health issues.

We also found two glucosylceramidases, *Gba* and *Gba2*, to be transcriptionally upregulated under chronic psychosocial stress. This could also contribute to increased Cer levels, resulting from the hydrolysis of glucosylceramide. Chronic psychosocial stress also induced increased expression *Ormdl2. Ormdl2* belongs to the evolutionarily conserved family of ORM-like proteins, which are central regulators of SL metabolism ([@B46]). *Ormdl* proteins are negative regulators of *de novo* ceramide synthesis via inhibition of serine palmitoyltransferase (SPTLC), the first and rate-limiting enzyme in SL production. However, *Ormdl* proteins can also stimulate *de novo* synthesis of complex SL downstream of SPTLC in yeast ([@B47]) via a mechanism that potentially involves CerS activity ([@B48]). Sphingomyelinase-like phosphodiesterase 3b (MGI symbol: *Smpdl3b*) is a GPI-anchored SM phosphodiesterase with relevance for cellular lipid composition ([@B49]). Knockdown of *Smpdl3b* in RAW264.7 macrophages results in decreased Cer level, indicating that the protein acts as an enzyme and generates Cer.

In summary, our analysis provides first evidence that chronic psychosocial stress has an impact on the hepatic SL metabolism in mice. Whether this relates to the primary stress response, e.g., secretion of glucocorticoids and catecholamines,---not mutually exclusively---or to the strong connection of SL with inflammation and oxidative stress ([@B50]) needs to be determined in future studies. Similar changes of the SL metabolism might be involved in the development of stress-associated pathologies in humans, and key enzymes of SL metabolism such as ASM ([@B51]) and *CerS6* ([@B52]) might constitute therapeutic targets to prevent or treat such conditions.
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